{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:27:44Z","timestamp":1787113664662,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["K01 DA053159"],"award-info":[{"award-number":["K01 DA053159"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R01 DA046049"],"award-info":[{"award-number":["R01 DA046049"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10461-026-05071-z","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:42:17Z","timestamp":1773488537000},"page":"2461-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of a Provider-Specific Anticipated Stigma Scale for People Who Inject Drugs"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-1360","authenticated-orcid":false,"given":"Roman","family":"Ivasiy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Earnshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimi","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Ompad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky N.","family":"Bluthenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan M.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"Supplement_5","key":"5071_CR1","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","volume":"222","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016\u20132019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supplement_5):S239\u201349.","journal-title":"J Infect Dis"},{"issue":"6","key":"5071_CR2","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/S2352-3018(20)30082-5","volume":"7","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Sypsa V, Feelemyer J, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Lancet HIV. 2020;7(6):e434\u201342.","journal-title":"Lancet HIV"},{"key":"5071_CR3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6916a2","author":"A Atkins","year":"2020","unstructured":"Atkins A. Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs\u2014Cabell County, West Virginia, 2018\u20132019. MMWR Morb Mortal Wkly Rep. 2020. https:\/\/doi.org\/10.15585\/mmwr.mm6916a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5071_CR4","unstructured":"National Health Care for the Homeless C. Improving HIV prevention and treatment access: case report from Knox County, TN, 2025."},{"key":"5071_CR5","unstructured":"Hamilton County Public H. Plan to END THE HIV EPIDEMIC: Hamilton County, Ohio. 2025. https:\/\/www.hamiltoncountyhealth.org\/wp-content\/uploads\/Hamilton-EHE-Plan.pdf."},{"key":"5071_CR6","unstructured":"New York City Department of Health Mental Hygiene. New York State\u2019s integrated HIV prevention and care plan 2022\u20132026, 2023."},{"key":"5071_CR7","unstructured":"Philadelphia Department of Public H. HIV spread among people who inject drugs, 2018."},{"issue":"11","key":"5071_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/cid\/ciaa507","volume":"72","author":"NW Furukawa","year":"2021","unstructured":"Furukawa NW, Blau EF, Reau Z, et al. Missed opportunities for human immunodeficiency virus (HIV) testing during injection drug use\u2013related healthcare encounters among a cohort of persons who inject drugs with HIV diagnosed during an outbreak\u2014Cincinnati\/Northern Kentucky, 2017\u20132018. Clin Infect Dis. 2021;72(11):1961\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5071_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.15585\/mmwr.mm6708a6","volume":"67","author":"ME Evans","year":"2018","unstructured":"Evans ME, Labuda SM, Hogan V, et al. Notes from the field: HIV infection investigation in a rural area\u2014West Virginia, 2017. Morb Mortal Wkly Rep. 2018;67(8):257.","journal-title":"Morb Mortal Wkly Rep"},{"key":"5071_CR10","unstructured":"Minnesota Department of H. Health advisory: HIV outbreak in persons who inject drugs (PWID). Updated 1\/2\/2021. 2025-04-23T10:38:10Z 2021. https:\/\/www.health.state.mn.us\/communities\/ep\/han\/2020\/feb3hiv.pdf."},{"key":"5071_CR11","unstructured":"Oregon Health A. Health alert: health officials alert public to increase in HIV infections among people who use drugs. Updated 1\/2\/2021. 2025-04-23T10:38:10Z 2021. https:\/\/multco.us\/multnomah-county\/news\/health-officials-alert-public-increase-hiv-infections-among-people-who-use."},{"key":"5071_CR12","unstructured":"Alaska Department of H, Human S. HIV update\u2015Alaska, 2018. 2025-04-23T10:38:10Z 2018. http:\/\/www.epi.alaska.gov\/bulletins\/docs\/b2019_06.pdf."},{"key":"5071_CR13","unstructured":"New York State Department of H. Health advisory: increased number of HIV and STI diagnoses in Orange County. Updated 1\/2\/2021. 2025-04-23T10:38:10Z 2021. https:\/\/www.health.ny.gov\/diseases\/aids\/providers\/health_advisories\/docs\/september_2018.pdf."},{"key":"5071_CR14","doi-asserted-by":"crossref","unstructured":"Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, Indiana, 2011\u20132015: a modeling study. Lancet HIV2018; 5","DOI":"10.1016\/S2352-3018(18)30176-0"},{"issue":"5","key":"5071_CR15","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.amepre.2021.04.037","volume":"61","author":"SE Buskin","year":"2021","unstructured":"Buskin SE, Erly SJ, Glick SN, et al. Detection and response to an HIV cluster: people living homeless and using drugs in Seattle, Washington. Am J Prev Med. 2021;61(5):S160\u20139.","journal-title":"Am J Prev Med"},{"key":"5071_CR16","doi-asserted-by":"crossref","unstructured":"Gonsalves GS, David Paltiel A, Thornhill T, et al. The dynamics of infectious diseases associated with injection drug use in Lawrence and Lowell, Massachusetts. Open forum infectious diseases; 2021: Oxford University Press US; 2021. p. ofab128.","DOI":"10.1093\/ofid\/ofab128"},{"issue":"15","key":"5071_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","volume":"68","author":"MR Golden","year":"2019","unstructured":"Golden MR, Lechtenberg R, Glick SN, et al. Outbreak of human immunodeficiency virus infection among persons who inject drugs\u2014King County, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"5071_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson E, John B, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"issue":"10279","key":"5071_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(21)00396-2","volume":"397","author":"AA Adimora","year":"2021","unstructured":"Adimora AA, Ramirez C, Poteat T, et al. HIV and women in the USA: what we know and where to go from here. Lancet. 2021;397(10279):1107\u201315.","journal-title":"Lancet"},{"key":"5071_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.drugalcdep.2018.06.017","volume":"190","author":"LM Nerlander","year":"2018","unstructured":"Nerlander LM, Hoots BE, Bradley H, et al. HIV infection among MSM who inject methamphetamine in 8 US cities. Drug Alcohol Depend. 2018;190:216\u201323.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5071_CR21","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.18899","volume":"17","author":"DJ Escudero","year":"2014","unstructured":"Escudero DJ, Lurie MN, Kerr T, Howe CJ, Marshall BD. HIV pre\u2010exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research. J Int AIDS Soc. 2014;17(1):18899.","journal-title":"J Int AIDS Soc"},{"key":"5071_CR22","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s10461-019-02682-7","volume":"24","author":"W McFarland","year":"2020","unstructured":"McFarland W, Lin J, Santos G-M, Arayasirikul S, Raymond HF, Wilson E. Low PrEP awareness and use among people who inject drugs, San Francisco, 2018. AIDS Behav. 2020;24:1290\u20133.","journal-title":"AIDS Behav"},{"key":"5071_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0166-x","volume":"14","author":"SM Walters","year":"2017","unstructured":"Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14:1\u201312.","journal-title":"Harm Reduct J"},{"key":"5071_CR24","unstructured":"Centers for Disease Control Prevention. Pre-exposure prophylaxis (PrEP). 2023. https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html."},{"key":"5071_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160\u201377.","journal-title":"AIDS Behav"},{"key":"5071_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108706","volume":"223","author":"S Meyers","year":"2021","unstructured":"Meyers S, Earnshaw V, D\u2019Ambrosio B, Courchesne N, Werb D, Smith L. The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature. Drug Alcohol Depend. 2021;223:108706.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5071_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1037\/sah0000426","volume":"8","author":"SM Walters","year":"2023","unstructured":"Walters SM, Kerr J, Cano M, Earnshaw V, Link B. Intersectional stigma as a fundamental cause of health disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time. Stigma Health. 2023;8(3):325.","journal-title":"Stigma Health"},{"issue":"3","key":"5071_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugpo.2009.10.010","volume":"21","author":"JF Kelly","year":"2010","unstructured":"Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202\u20137.","journal-title":"Int J Drug Policy"},{"key":"5071_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/08901171251330710","author":"R Turpin","year":"2024","unstructured":"Turpin R, Camp AD, Mandell C, et al. \u201cHealthcare doesn\u2019t care\u201d: a mixed-methods study on healthcare stigma and PrEP use among black sexual minority men. Am J Health Promot. 2024. https:\/\/doi.org\/10.1177\/08901171251330710.","journal-title":"Am J Health Promot"},{"issue":"6","key":"5071_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11904-020-00533-y","volume":"17","author":"SK Calabrese","year":"2020","unstructured":"Calabrese SK. Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Curr HIV AIDS Rep. 2020;17(6):579\u201388.","journal-title":"Curr HIV AIDS Rep"},{"issue":"2","key":"5071_CR31","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S2468-2667(23)00312-2","volume":"9","author":"ML Hatzenbuehler","year":"2024","unstructured":"Hatzenbuehler ML, Lattanner MR, McKetta S, Pachankis JE. Structural stigma and LGBTQ+ health: a narrative review of quantitative studies. Lancet Public Health. 2024;9(2):e109\u201327.","journal-title":"Lancet Public Health"},{"issue":"4","key":"5071_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s44159-022-00034-2","volume":"1","author":"VA Earnshaw","year":"2022","unstructured":"Earnshaw VA, Watson RJ, Eaton LA, Brousseau NM, Laurenceau J-P, Fox AB. Integrating time into stigma and health research. Nat Rev Psychol. 2022;1(4):236\u201347.","journal-title":"Nat Rev Psychol"},{"issue":"3","key":"5071_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/00914509231179226","volume":"50","author":"BD Scher","year":"2023","unstructured":"Scher BD, Neufeld SD, Butler A, et al. \u201cCriminalization causes the stigma\u201d: perspectives from people who use drugs. Contemp Drug Probl. 2023;50(3):402\u201325.","journal-title":"Contemp Drug Probl"},{"issue":"S1","key":"5071_CR34","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.2105\/AJPH.2022.307037","volume":"113","author":"JR Pamplin","year":"2023","unstructured":"Pamplin JR, Rouhani S, Davis CS, King C, Townsend TN. Persistent criminalization and structural racism in US drug policy: the case of overdose good Samaritan laws. Am J Public Health. 2023;113(S1):S43\u20138.","journal-title":"Am J Public Health"},{"key":"5071_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1295818","volume":"15","author":"S El Hayek","year":"2024","unstructured":"El Hayek S, Foad W, De Filippis R, et al. Stigma toward substance use disorders: a multinational perspective and call for action. Front Psychiatry. 2024;15:1295818.","journal-title":"Front Psychiatry"},{"key":"5071_CR36","unstructured":"Quinn DM, Chaudoir SR. Living with a concealable stigmatized identity: psychological, physical, and behavioral consequences. Psychol Bull. 2009."},{"issue":"2","key":"5071_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/add.14799","volume":"115","author":"LR Smith","year":"2020","unstructured":"Smith LR, Mittal ML, Wagner K, Copenhaver MM, Cunningham CO, Earnshaw VA. Factor structure, internal reliability and construct validity of the methadone maintenance treatment stigma mechanisms scale (MMT-SMS). Addiction. 2020;115(2):354\u201367.","journal-title":"Addiction"},{"key":"5071_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.02.019","volume":"162","author":"LR Smith","year":"2016","unstructured":"Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;162:34\u201343.","journal-title":"Drug Alcohol Depend"},{"key":"5071_CR39","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s10461-013-0437-9","volume":"17","author":"VA Earnshaw","year":"2013","unstructured":"Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17:1785\u201395.","journal-title":"AIDS Behav"},{"issue":"4","key":"5071_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1089\/apc.2018.0282","volume":"33","author":"WS Rice","year":"2019","unstructured":"Rice WS, Turan B, Fletcher FE, et al. A mixed methods study of anticipated and experienced stigma in health care settings among women living with HIV in the United States. AIDS Patient Care STDS. 2019;33(4):184\u201395.","journal-title":"AIDS Patient Care STDS"},{"key":"5071_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"5071_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11904-022-00619-9","volume":"19","author":"KE Lancaster","year":"2022","unstructured":"Lancaster KE, Endres-Dighe S, Sucaldito AD, et al. Measuring and addressing stigma within HIV interventions for people who use drugs: a scoping review of recent research. Curr HIV AIDS Rep. 2022;19(5):301\u201311.","journal-title":"Curr HIV AIDS Rep"},{"key":"5071_CR43","doi-asserted-by":"publisher","first-page":"100237","DOI":"10.1016\/j.dadr.2024.100237","volume":"11","author":"A Spata","year":"2024","unstructured":"Spata A, Gupta I, Lear MK, Lunze K, Luoma JB. Substance use stigma: a systematic review of measures and their psychometric properties. Drug Alcohol Depend Rep. 2024;11:100237.","journal-title":"Drug Alcohol Depend Rep"},{"key":"5071_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10862-012-9323-4","volume":"35","author":"JB Luoma","year":"2013","unstructured":"Luoma JB, Nobles RH, Drake CE, et al. Self-stigma in substance abuse: development of a new measure. J Psychopathol Behav Assess. 2013;35:223\u201334.","journal-title":"J Psychopathol Behav Assess"},{"issue":"1","key":"5071_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12954-023-00831-9","volume":"20","author":"SN Kapadia","year":"2023","unstructured":"Kapadia SN, Aponte-Melendez Y, Rodriguez A, et al. \u201cTreated like a human being\u201d: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City. Harm Reduct J. 2023;20(1):95.","journal-title":"Harm Reduct J"},{"issue":"1","key":"5071_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00518-z","volume":"18","author":"U Ibragimov","year":"2021","unstructured":"Ibragimov U, Beane S, Pro G, Long E, Fuller L, Madden L. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky. Harm Reduct J. 2021;18(1):1\u201311.","journal-title":"Harm Reduct J"},{"issue":"9","key":"5071_CR47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/10826084.2019.1624774","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HLF, Browning CR, Malvestutto C, Bridges JFP, Young AM. Syringe service program utilization, barriers, and preferences for design in rural Appalachia: differences by current injection status. Subst Use Misuse. 2020;55(9):1385\u201395.","journal-title":"Subst Use Misuse"},{"key":"5071_CR48","volume":"126","author":"TR Broady","year":"2024","unstructured":"Broady TR, Brener L, Cama E, Hopwood M, Treloar C. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs. Int J Drug Policy. 2024;126:104329.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"5071_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231424","volume":"15","author":"Y Jo","year":"2020","unstructured":"Jo Y, Bartholomew TS, Doblecki-Lewis S, et al. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS ONE. 2020;15(4):e0231424.","journal-title":"PLoS ONE"},{"issue":"12","key":"5071_CR50","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1080\/09540121.2024.2390067","volume":"36","author":"HL Surratt","year":"2024","unstructured":"Surratt HL, Brown S, Burton AL, et al. Examining HIV pre-exposure prophylaxis (PrEP) acceptability among rural people who inject drugs: predictors of PrEP interest among syringe service program clients. AIDS Care. 2024;36(12):1858\u201368.","journal-title":"AIDS Care"},{"key":"5071_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2025.100593","volume":"8","author":"CF Akiba","year":"2025","unstructured":"Akiba CF, Megerian CE, Chung EO, Morris T. The role of stigma in impeding implementation of harm reduction services in San Francisco. SSM Qual Res Health. 2025;8:100593.","journal-title":"SSM Qual Res Health"},{"issue":"2","key":"5071_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1037\/a0023244","volume":"17","author":"KF Balsam","year":"2011","unstructured":"Balsam KF, Molina Y, Beadnell B, Simoni J, Walters K. Measuring multiple minority stress: the LGBT people of color microaggressions scale. Cult Divers Ethn Minor Psychol. 2011;17(2):163.","journal-title":"Cult Divers Ethn Minor Psychol"},{"issue":"2","key":"5071_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1037\/cou0000062","volume":"62","author":"JA Lewis","year":"2015","unstructured":"Lewis JA, Neville HA. Construction and initial validation of the gendered racial microaggressions scale for Black women. J Couns Psychol. 2015;62(2):289.","journal-title":"J Couns Psychol"},{"key":"5071_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.socscimed.2018.12.016","volume":"226","author":"AI Scheim","year":"2019","unstructured":"Scheim AI, Bauer GR. The intersectional discrimination index: development and validation of measures of self-reported enacted and anticipated discrimination for intercategorical analysis. Soc Sci Med. 2019;226:225\u201335.","journal-title":"Soc Sci Med"},{"key":"5071_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10461-021-03488-2","volume":"26","author":"SM Walters","year":"2022","unstructured":"Walters SM, Frank D, Van Ham B, et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2022;26:1\u201313.","journal-title":"AIDS Behav"},{"key":"5071_CR56","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S448147","author":"S Anwar","year":"2024","unstructured":"Anwar S, et al. Gender and drug use discrimination among people who inject drugs: an intersectional approach. Drug Alcohol Depend. 2024. https:\/\/doi.org\/10.2147\/IJWH.S448147.","journal-title":"Drug Alcohol Depend"},{"key":"5071_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00581-8","author":"M Paschen-Wolff","year":"2024","unstructured":"Paschen-Wolff M, et al. Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study. Subst Abuse Treat Prev Policy. 2024. https:\/\/doi.org\/10.1186\/s13011-023-00581-8.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"5071_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102671","volume":"77","author":"SM Walters","year":"2020","unstructured":"Walters SM, Coston B, Neaigus A, et al. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. Int J Drug Policy. 2020;77:102671.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"5071_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/135910539700200305","volume":"2","author":"DR Williams","year":"1997","unstructured":"Williams DR, Yu Y, Jackson JS, Anderson NB. Racial differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2(3):335\u201351.","journal-title":"J Health Psychol"},{"key":"5071_CR60","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s10508-021-02031-7","volume":"50","author":"AM Heads","year":"2021","unstructured":"Heads AM, Hill MJ, Suchting R, Yammine L, Gilmore-Thomas A. Predictors of anticipated PrEP stigma among women with self-reported problematic substance use: implications for engaging women in the PrEP care continuum. Arch Sex Behav. 2021;50:2955\u201364.","journal-title":"Arch Sex Behav"},{"key":"5071_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209270","volume":"159","author":"K McLean","year":"2024","unstructured":"McLean K, Murphy J, Kruis N. \u201cI think we\u2019re getting better but we\u2019re still not there\u201d: provider-based stigma and perceived barriers to care for people who use opioids (PWUO). J Subst Use Addict Treat. 2024;159:209270.","journal-title":"J Subst Use Addict Treat"},{"key":"5071_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"K Biello","year":"2018","unstructured":"Biello K, Bazzi A, Mimiaga M, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15:1\u201312.","journal-title":"Harm Reduct J"},{"issue":"9","key":"5071_CR63","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1037\/amp0000744","volume":"75","author":"VA Earnshaw","year":"2020","unstructured":"Earnshaw VA. Stigma and substance use disorders: a clinical, research, and advocacy agenda. Am Psychol. 2020;75(9):1300.","journal-title":"Am Psychol"},{"key":"5071_CR64","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1007\/s10461-020-02982-3","volume":"25","author":"AW Batchelder","year":"2021","unstructured":"Batchelder AW, Foley JD, Wirtz MR, Mayer K, O\u2019Cleirigh C. Substance use stigma, avoidance coping, and missed HIV appointments among MSM who use substances. AIDS Behav. 2021;25:1454\u201363.","journal-title":"AIDS Behav"},{"key":"5071_CR65","unstructured":"Cipollina R, Wang K. Psychology of sexual orientation and gender diversity. 2024."},{"key":"5071_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112588","volume":"269","author":"SS Ganesh","year":"2025","unstructured":"Ganesh SS, Goldshear JL, Wilkins P, et al. Risk factors for infective endocarditis and serious injection related infections among people who inject drugs in Los Angeles, CA and Denver, CO. Drug Alcohol Depend. 2025;269:112588.","journal-title":"Drug Alcohol Depend"},{"issue":"Supplement_5","key":"5071_CR67","doi-asserted-by":"publisher","first-page":"S451","DOI":"10.1093\/infdis\/jiaa012","volume":"222","author":"JR Coyle","year":"2020","unstructured":"Coyle JR, Freeland M, Eckel ST, Hart AL. Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic. J Infect Dis. 2020;222(Supplement_5):S451\u20137.","journal-title":"J Infect Dis"},{"key":"5071_CR68","unstructured":"SAS\u00ae 9.4. Procedures guide. 2014."},{"issue":"2","key":"5071_CR69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1742395311429393","volume":"8","author":"VA Earnshaw","year":"2012","unstructured":"Earnshaw VA, Quinn DM, Park CL. Anticipated stigma and quality of life among people living with chronic illnesses. Chronic Illn. 2012;8(2):79\u201388.","journal-title":"Chronic Illn"},{"issue":"2","key":"5071_CR70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/ACM.0000000000005467","volume":"99","author":"E Magnan","year":"2024","unstructured":"Magnan E, Weyrich M, Miller M, et al. Stigma against patients with substance use disorders among health care professionals and trainees and stigma-reducing interventions: a systematic review. Acad Med. 2024;99(2):221\u201331.","journal-title":"Acad Med"},{"issue":"1-2","key":"5071_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335.","journal-title":"Drug Alcohol Depend"},{"key":"5071_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108486","volume":"131","author":"J Bielenberg","year":"2021","unstructured":"Bielenberg J, Swisher G, Lembke A, Haug NA. A systematic review of stigma interventions for providers who treat patients with substance use disorders. J Subst Abuse Treat. 2021;131:108486.","journal-title":"J Subst Abuse Treat"},{"key":"5071_CR73","volume-title":"Using Mplus for structural equation modeling: a researcher's guide","author":"EK Kelloway","year":"2014","unstructured":"Kelloway EK. Using Mplus for structural equation modeling: a researcher\u2019s guide. Thousand Oaks: Sage Publications; 2014."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05071-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05071-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05071-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:16:19Z","timestamp":1787112979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05071-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05071-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"4 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no declarations of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}